Power Purchase Agreement with SK Innovation E&S to add 16 MW of renewable electricity capacity starting in December 2027 ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Thinking about picking up some Merck KGaA shares, but wondering if the current price tag does the business justice? You're not alone. Value hunters and long-term investors keep asking the same ...

As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at ...

Drugs that interfere with a way tumors repair damage to their DNA have become valuable tools for treating certain cancers. Some big pharmaceutical companies are developing drugs that improve on this ...

Merck KGaA, a German integrated science, pharmaceutical, and technology company with a significant market presence in the U.S., is the latest ...

After nearly two decades spent working with the World Health Organization (WHO) to supply billions of praziquantel tablets to help treat schistosomiasis, Merck KGaA has recently tacked on an ...

Merck KGaA reported its first-quarter 2025 results, with sales and underlying EBITDA growing by 3.2% and 5.6%, respectively—in line with company-compiled consensus estimates. Shares traded 5% lower ...

The artificial intelligence deals keep coming at Merck KGaA. Days after the pharma put out news of two new AI pacts, Quris-AI has shared details of the expansion of the drug toxicity prediction ...

Big pharma performed well in 2022, but the time to trim is drawing close. As a more diversified investment, I believe former parent company of Merck & Co, Merck KGaA offers a better long-term ...

Merck KGaA is bolstering its drug discovery efforts by turning to two artificial intelligence companies, BenevolentAI and Exscientia. Details are scant, but Merck KGaA said the multi-year agreements ...

Sometimes you get really lucky with "timing" your valuation articles. This was the case for my article on Merck KGaA (OTCPK:MKGAF), a company I wrote about back in November of 2023. This coverage can ...